Evidence map›Paper›PMID 8609915›Full record

ArticleMolecular and cellular biochemistry1995

A role for cAMP in angiotensin II mediated inhibition of cell growth in AT1A receptor-transfected CHO-K1 cells.

T J Thekkumkara, J Du, C Zwaagstra, K M Conrad, J Krupinski, K M Baker

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Overexpression of NaOncotarget · 2018
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

T J ThekkumkaraWeis Center for Research, Geisinger Clinic, Danville, PA 17822, USA.
J Du
C Zwaagstra
K M Conrad
J Krupinski
K M Baker
Geisinger Medical Center · US

Funding

REGULATION OF CARDIAC HYPERTROPHY BY ANGIOTENSINSR01HL044883 · NHLBI · WEIS CENTER FOR RESEARCH-GEISINGER CLINC · PI BAKER, KENNETH MELVIN · 1990 to 2002
$801k
REGULATION OF CARDIAC SECOND MESSENGERS BY ANGIOTENSINR01HL044379 · NHLBI · WEIS CENTER FOR RESEARCH-GEISINGER CLINC · PI BAKER, KENNETH MELVIN · 1991 to 1993
–
STRUCTURAL DIVERSITY IN THE ADENYLYL CYCLASE FAMILYR29GM046395 · NIGMS · WEIS CENTER FOR RESEARCH-GEISINGER CLINC · PI KRUPINSKI, JOHN · 1991 to 1995
–
NHLBI NIH HHS HL 44379NHLBI NIH HHS HL 44883NIGMS NIH HHS GM 46395
6 · The paper itself

Abstract

G-protein coupled Angiotensin II receptors (AT1A), mediate cellular responses through multiple signal transduction pathways. In AT1A receptor-transfected CHO-K1 cells (T3CHO/AT1A), angiotensin II (AII) stimulated a dose-dependent EC50 = 3.3 nM) increase in cAMP accumulation, which was inhibited by the selective AT1, nonpeptide receptor antagonist EXP3174. Activation of protein kinase C, or increasing intracellular Ca2+ with ATP, the calcium ionophore A23187 or ionomycin failed to stimulate cAMP accumulation. Thus, AII-induced cAMP accumulation was not secondary to activation of a protein kinase C- or ca2+/calmodulin-dependent pathway. Since cAMP has an established role in cellular growth responses, we investigated the effect of the AII-mediated increase in cAMP on cell number and [3H]thymidine incorporation in T3CHOA/AT1A cells. AII (1 microM) significantly inhibited cell number (51% at 96 h) and [3H]thymidine incorporation of 68% at 24 h) compared to vehicle controls. These effects were blocked by EXP3174, confirming that these responses were mediated through the AT1 receptor. Forskolin (10 microM) and the cAMP analog dibutyryl-cAMP (1 mM) also inhibited [3H]thymidine incorporation by 55 and 25% respectively. We extended our investigation on the effect of AII-stimulated increases in cAMP, to determine the role for established growth related signaling events, i.e., mitogen-activated protein kinase activity an tyrosine phosphorylation of cellular proteins. AII-stimulated mitogen-activated protein kinase activity and phosphorylation of the 42 and 44 kD forms. These events were unaffected by forskolin stimulated increases in cAMP, thus the AII-stimulated mitogen-activated protein kinase activity was independent of cAMP in these cells. AII also stimulated tyrosine phosphorylation of a number of cellular proteins in T3CHO/AT1A cells, in particular at 127 kD protein. The phosphorylation of the 127 kD protein was transient, reaching a maximum at 1 min, and returning to basal levels within 10 min. The dephosphorylation of this protein was blocked by a selective inhibitor of cAMP dependent protein kinase A, H89-dihydrochloride and preexposure to forskolin prevented the AII-induced transient tyrosine phosphorylation of the 127 kD protein. These data suggest that cAMP, and therefore protein kinase A can contribute to AII-mediated growth inhibition by stimulating the dephosphorylation of substrates that are tyrosine phosphorylated in response to AII.

Indexed as

Angiotensin IIAnimalsCell DivisionCHO CellsCricetinaeCyclic AMPGene Transfer TechniquesReceptors, AngiotensinSignal TransductionVasoconstrictor AgentsAngiotensin IICyclic AMPReceptors, AngiotensinVasoconstrictor Agents

Identifiers

PMID8609915
OpenAlexW236795115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.